CN114366775A - Eye-protecting nutrient solution - Google Patents

Eye-protecting nutrient solution Download PDF

Info

Publication number
CN114366775A
CN114366775A CN202011416260.9A CN202011416260A CN114366775A CN 114366775 A CN114366775 A CN 114366775A CN 202011416260 A CN202011416260 A CN 202011416260A CN 114366775 A CN114366775 A CN 114366775A
Authority
CN
China
Prior art keywords
percent
vitamin
eye
nutrient solution
protecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011416260.9A
Other languages
Chinese (zh)
Inventor
金锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huimou International Biotechnology Guangdong Co ltd
Original Assignee
Huimou International Biotechnology Guangdong Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huimou International Biotechnology Guangdong Co ltd filed Critical Huimou International Biotechnology Guangdong Co ltd
Priority to CN202011416260.9A priority Critical patent/CN114366775A/en
Publication of CN114366775A publication Critical patent/CN114366775A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287Chrysanthemum, e.g. daisy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/44Ebenaceae (Ebony family), e.g. persimmon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482Cassia, e.g. golden shower tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536Prunella or Brunella (selfheal)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/56Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/85Verbenaceae (Verbena family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/10Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the technical field of health-care drinks, and particularly relates to eye-protecting nutrient solution. An eye-protecting nutrient solution comprises the following components in percentage by weight: 3-5% of hydrolyzed procyanidin, 4-5% of hydrolyzed vegetable protein, 1-2% of dipotassium glycyrrhizinate, 1-2% of riboflavin, 1-2% of retinol, 3-5% of soluble protein, 3-5% of vitamin, 1-2% of yeast polypeptide and the balance of water. The invention provides the eye-protecting nutrient solution which has low cost and simple production, is sprayed to eyes by an atomizer and has the functions of conditioning eyes of a human body and relieving fatigue.

Description

Eye-protecting nutrient solution
Technical Field
The invention belongs to the technical field of health-care spraying, and particularly relates to eye-protecting nutrient solution.
Background
Vision refers to the ability of the retina to resolve images. The quality of vision is determined by the amount of ability of the retina to resolve images, however, when the refractive medium of the eye (e.g., cornea, lens, vitreous, etc.) becomes cloudy or refractive errors (including myopia, hyperopia, astigmatism, etc.) exist, vision of the eye declines even when the retina functions well. Refractive media opacities of the eye can be treated surgically and refractive errors require correction by lenses.
With the development of society, the large-area popularization of electronic products brings about a plurality of vision problems, and the long-time use of eyes causes the problems of vision deterioration, eye fatigue, eye turbidity and the like of teenagers, middle-aged and even old people. The existing solutions mostly adopt means such as operations, drug therapy such as eye drops, and therapy of medical instruments to improve eyesight, and if people want to generate an eye protection effect through diet therapy in daily life, the effect is weak.
In view of the above problems, some vision nutrient solutions have been produced, such as the technical content disclosed in chinese patent CN 1041801C: a kind of eyesight nutrient solution, by rhizoma Dioscoreae, herba Agastaches, hyacinth bean, fructus Lycii, Poria, Mori fructus, flos Chrysanthemi, carrot aqueous extract concentrate, flavoring agent and water content make up, every component is counted according to the weight percent, aqueous extract concentrate 10-20%, flavoring agent 0.5-3% and water content 80-88%, wherein the aqueous extract concentrate contains crude drug amount 200 and 500g per 100 ml; the Chinese medicine composition is prepared with Chinese yam 10-20 wt%, agastache 6-10 wt%, hyacinth bean 10-20 wt%, wolfberry fruit 8-16 wt%, tuckahoe 8-16 wt%, mulberry 10-20 wt%, chrysanthemum 6-10 wt% and carrot 10-20 wt%.
Also as the technical content disclosed in chinese patent CN 108720024A: an active multi-enzyme vitamin cell nutrient solution contains fresh fruit pulp, tomato juice, carrot juice, glucose, fructo-oligosaccharide, lactobacillus powder, inulin, plant collagen, amino acid, vitamin E and vitamin C, wherein the fresh fruit pulp is selected from the following components: the lactobacillus powder is composed of lactobacillus acidophilus, lactobacillus casei, bifidobacterium longum, streptococcus thermophilus, lactococcus lactis and subsp lactis, wherein the mass ratio of the lactobacillus acidophilus to the lactobacillus casei to the bifidobacterium longum to the streptococcus thermophilus to the lactococcus lactis to the subsp lactis is 1:1:1:1: 1.
The technical content disclosed in the Chinese patent CN111558031A is as follows: the pure plant multifunctional eye special nutrient solution is characterized by comprising the following raw materials in parts by weight: 1.5 to 1 percent of angelica sinensis peptide, 0.5 to 1 percent of ginseng peptide, 0.5 to 1 percent of sea cucumber peptide, 0.5 to 1 percent of balsam pear peptide, 9 to 5 percent of astragalus root, 6 to 7 percent of rhodiola rosea, 5 to 4 percent of houttuynia cordata, 4 to 5 percent of peach kernel, 5 to 6 percent of safflower, 4 to 5 percent of kudzu root, 2 to 3 percent of root of straight ladybell, 3 to 2 percent of figwort root, 5 to 7 percent of salvia miltiorrhiza, 2 to 3 percent of wine-treated rhubarb, 4 to 5 percent of pipewort, 3 to 5 percent of mother of pearl, 3 to 2 percent of feather cockscomb seed, 4 to 5 percent of mulberry leaf, 5 to 2 percent of Huaihu chrysanthemum, 6 to 3 percent of mint, 5 to 2 percent of borneol, 3 to 4 percent of cassia seed, 3 to 4 percent of beta-carotene, 5 to 3 percent of lutein ester, 4-5% of taurine, 3-3% of vitamin B22, 3-2% of biotin, 2-2% of vitamin B31 and 1-2% of resveratrol.
Although the prior art is called to realize the function and effect of eye protection, the formula is too simple and old or too complex, the cost is higher, and the tea is not suitable for daily drinking.
Disclosure of Invention
The invention aims to provide the eye-protecting nutrient solution which has low cost and simple production, is sprayed to eyes by an atomizer and has the functions of conditioning eyes of a human body and relieving fatigue. In order to achieve the purpose, the invention adopts the following technical scheme:
an eye-protecting nutrient solution comprises the following components in percentage by weight:
3 to 5 percent of hydrolyzed procyanidine,
4 to 5 percent of hydrolyzed vegetable protein,
1 to 2 percent of dipotassium glycyrrhizinate,
1 to 2 percent of riboflavin,
1 to 2 percent of retinol,
3 to 5 percent of soluble protein,
3 to 5 percent of vitamin,
the balance of water.
On the basis of the technical scheme, the invention can also adopt the following further technical scheme:
specifically, the paint also comprises the following components in percentage by weight:
10 to 20 percent of traditional Chinese medicine extract,
15 to 30 percent of fruit extract,
5 to 10 percent of flavoring agent,
2 to 5 percent of vitamin,
the balance of water.
Specifically, the traditional Chinese medicine extract comprises the following components in percentage by weight:
3 to 5 percent of tuckahoe,
9 to 18 percent of Xiasangju,
15 to 25 percent of medlar,
15 to 25 percent of cassia seed,
1 to 3 percent of astragalus root,
12 to 20 percent of buddleja officinalis,
2 to 4 percent of fructus viticis,
the balance of water.
Wherein Poria has effects of promoting diuresis, eliminating dampness, invigorating spleen, and calming heart.
The main components of the prunella vulgaris, the mulberry leaf and the wild chrysanthemum flower. Spica Prunellae enters liver and gallbladder meridians, integrates pure yang qi, nourishes liver-related jueyin blood vessels, treats yin with yang, is a "holy drug" for clearing and protecting liver, folium Mori is good at calming liver wind, leaves are fragrant and also moves through lung collaterals to ventilate lung qi. Has the effects of dispelling wind and heat, clearing lung-heat, moistening dryness, removing liver fire and improving eyesight. The wild chrysanthemum flower is fragrant and sweet in taste, can tonify the two internal organs of the body, calm the liver, improve eyesight, clear heat and remove toxicity.
The medlar contains rich carotene, vitamin A, B1, B2, C, calcium, iron and the like, and is necessary nutrition for healthy eyes.
Semen Cassiae has effects of removing liver fire, improving eyesight, and loosening bowel to relieve constipation.
Radix astragali has effects of invigorating qi, consolidating superficial resistance, expelling toxin, expelling pus, promoting urination, and promoting granulation.
Flos Buddlejae is slightly cold in nature and sweet in taste, enters liver channel, has effects of clearing heat, nourishing liver, improving eyesight and removing nebula, and can be used for treating conjunctival congestion, swelling and pain, lacrimation, photophobia, nebula, liver deficiency, dim eyesight and blurred vision, and is a common medicine for ophthalmology.
Chastetree fruit is commonly used for headache due to exogenous pathogenic factors, dizziness, blurred vision, hyperdacryosis, pain in eyes, swelling and pain of gum, and spasm due to damp arthralgia.
Specifically, the fruit extract comprises the following components in percentage by weight:
5 to 8 percent of cucumber,
15% -20% of bananas,
8 to 15 percent of pear,
18 to 25 percent of persimmon,
20% -25% of oranges,
3 to 7 percent of mulberry,
the balance of water.
The fruits are rich in vitamin A, and can protect eye tissue and structure, maintain normal efficacy of rhodopsin of eye, and prevent and treat nyctalopia and xerophthalmia.
Specifically, the flavoring agent is xylitol or sucrose, so that the taste of the nutrient solution can be optimized.
Specifically, the vitamin is one or more of vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin C, and vitamin H. Vitamin A can protect eye tissue, structure, maintain normal function of rhodopsin, and prevent and treat nyctalopia and xerophthalmia. Vitamin B1 has effects in protecting optic nerve, maintaining normal vision, preventing optic nerve degeneration, and preventing cataract and other eye diseases.
Specifically, when the vitamins are vitamin A and vitamin B1, the mass ratio of the vitamin A to the vitamin B1 is 32: 45.
the invention has the following technical characteristics: the eye-protecting nutrient solution disclosed by the invention can be prepared by supplementing food materials and Chinese medicinal materials together from the simultaneous administration of food supplement and medicine supplement through the scientific proportion of the Chinese medicaments and the fruits, so that the respective effects are better exerted, the effect of helping the eyesight during daily drinking is realized, and the eye-protecting effects of relieving eye fatigue, clearing liver and improving eyesight, improving nyctalopia and the like can be realized.
Detailed Description
The following specific examples are further illustrative of the methods and techniques provided by the present invention and should not be construed as limiting the invention thereto.
The first embodiment of the invention provides an eye-protecting nutrient solution, which comprises the following components in percentage by weight:
10 percent of the traditional Chinese medicine extract,
15 percent of fruit extract,
5 percent of xylitol,
2 percent of vitamin A,
the balance of water.
Wherein, the traditional Chinese medicine extract comprises the following components in percentage by weight:
3 percent of tuckahoe, namely tuckahoe,
9 percent of summer mulberry and chrysanthemum,
15 percent of the medlar,
15 percent of cassia seed,
1 percent of astragalus root,
12 percent of the pale butterflybush flower,
2 percent of fructus viticis,
the balance of water.
Wherein the fruit extract comprises the following components in percentage by weight:
5 percent of cucumber,
15 percent of the bananas,
8 percent of pear,
18 percent of persimmon,
20 percent of the orange peel is added,
3 percent of mulberry fruit,
the balance of water.
In this embodiment, the eye-protecting nutritional liquid is prepared by mixing the herbal extract, the fruit extract and water, and then adding xylitol and vitamin a to the mixture.
The second embodiment provides an eye-protecting nutrient solution, which comprises the following components in percentage by weight:
20 percent of traditional Chinese medicine extract,
30 percent of fruit extract,
10 percent of xylitol,
the vitamin B is 15 percent,
the balance of water.
Wherein, the traditional Chinese medicine extract comprises the following components in percentage by weight:
5 percent of tuckahoe, namely,
18 percent of summer mulberry and chrysanthemum,
25 percent of the medlar,
25 percent of cassia seed,
3 percent of astragalus root,
20 percent of the butterflybush flower,
4 percent of fructus viticis.
Wherein the fruit extract comprises the following components in percentage by weight:
8 percent of cucumber,
20 percent of the bananas,
15 percent of pears,
25 percent of persimmon,
25 percent of the orange peel is added,
7% of mulberry.
In this embodiment, the eye-protecting nutritional liquid is prepared by mixing the herbal extract, the fruit extract and water, and then adding xylitol and vitamin B1 to mix.
In the third embodiment, the eye-protecting nutrient solution comprises the following components in percentage by weight:
15 percent of traditional Chinese medicine extract,
20 percent of fruit extract,
8 percent of cane sugar,
3 percent of vitamin A, and the like,
the balance of water.
Wherein, the traditional Chinese medicine extract comprises the following components in percentage by weight:
4 percent of tuckahoe, namely tuckahoe, the weight percentage of tuckahoe,
12 percent of summer mulberry and chrysanthemum,
20 percent of the medlar,
20 percent of cassia seed,
2 percent of astragalus root,
18 percent of the butterflybush flower,
3 percent of fructus viticis,
the balance of water.
Wherein the fruit extract comprises the following components in percentage by weight:
7 percent of cucumber,
18 percent of the bananas,
12 percent of pears,
20 percent of persimmon,
25 percent of the orange peel is added,
5 percent of mulberry fruit,
the balance of water.
In this embodiment, the eye-protecting nutritional liquid is prepared by mixing the herbal extract, the fruit extract, sucrose, vitamin a, and water together.
The fourth embodiment provides an eye-protecting nutrient solution, which comprises the following components in percentage by weight:
15 percent of traditional Chinese medicine extract,
20 percent of fruit extract,
8 percent of cane sugar,
the vitamin B is 13 percent,
the balance of water.
Wherein, the traditional Chinese medicine extract comprises the following components in percentage by weight:
4 percent of tuckahoe, namely tuckahoe, the weight percentage of tuckahoe,
12 percent of summer mulberry and chrysanthemum,
22 percent of the medlar,
20 percent of cassia seed,
2 percent of astragalus root,
19 percent of the pale butterflybush flower,
3 percent of fructus viticis,
the balance of water.
Wherein the fruit extract comprises the following components in percentage by weight:
7 percent of cucumber,
18 percent of the bananas,
12 percent of pears,
19 percent of persimmon,
25 percent of the orange peel is added,
5 percent of mulberry fruit,
the balance of water.
In this embodiment, the eye-protecting nutritional liquid is prepared by mixing the herbal extract, the fruit extract, sucrose, vitamin B1, and water.
The fifth embodiment provides an eye-protecting nutrient solution, which comprises the following components in percentage by weight:
18 percent of the traditional Chinese medicine extract,
25 percent of fruit extract,
7 percent of xylitol,
4 percent of vitamin A,
the balance of water.
Wherein, the traditional Chinese medicine extract comprises the following components in percentage by weight:
3 percent of tuckahoe, namely tuckahoe,
16 percent of summer mulberry and chrysanthemum,
21 percent of the medlar,
18 percent of cassia seed,
1 percent of astragalus root,
18 percent of the butterflybush flower,
3 percent of fructus viticis,
the balance of water.
Wherein the fruit extract comprises the following components in percentage by weight:
8 percent of cucumber,
19 percent of the bananas,
14 percent of pears,
23 percent of persimmon,
25 percent of the orange peel is added,
5 percent of mulberry fruit,
the balance of water.
In this embodiment, the preparation method of the eye-protecting nutritional liquid is to mix the traditional Chinese medicine extract and the fruit extract, and then add xylitol, vitamin a and water to mix them together.
The sixth embodiment provides an eye-protecting nutrient solution, which comprises the following components in percentage by weight:
5 percent of hydrolyzed procyanidin,
5 percent of hydrolyzed vegetable protein,
2 percent of dipotassium glycyrrhizinate,
1 percent of riboflavin,
2 percent of retinol,
3 percent of soluble protein,
1 percent of vitamin H,
18 percent of the traditional Chinese medicine extract,
25 percent of fruit extract,
7 percent of xylitol,
4 percent of vitamin A,
the vitamin B is 21 percent,
the vitamin B is 61 percent,
1 percent of folic acid,
1 percent of vitamin C,
the balance of water.
Wherein, the traditional Chinese medicine extract comprises the following components in percentage by weight:
3 percent of tuckahoe, namely tuckahoe,
16 percent of summer mulberry and chrysanthemum,
21 percent of the medlar,
18 percent of cassia seed,
1 percent of astragalus root,
18 percent of the butterflybush flower,
3 percent of fructus viticis,
the balance of water.
Wherein the fruit extract comprises the following components in percentage by weight:
8 percent of cucumber,
19 percent of the bananas,
14 percent of pears,
23 percent of persimmon,
25 percent of the orange peel is added,
5 percent of mulberry fruit,
the balance of water.
In this embodiment, the preparation method of the eye-protecting nutritional liquid is to mix the traditional Chinese medicine extract and the fruit extract, and then add xylitol, all vitamins and water to mix them together.
The vision nutrient solution comprises the following components in percentage by weight:
10 to 20 percent of water extract concentrated solution,
0.5 to 3 percent of flavoring agent,
80 to 88 percent of water,
wherein the water extraction concentrated solution contains 500g of crude drug in 200 g per 100 ml;
the Chinese medicine composition is prepared with Chinese yam 10-20 wt%, agastache 6-10 wt%, hyacinth bean 10-20 wt%, wolfberry fruit 8-16 wt%, tuckahoe 8-16 wt%, mulberry 10-20 wt%, chrysanthemum 6-10 wt% and carrot 10-20 wt%.
In contrast tests, 120 myopic volunteers are selected, the age interval is 18-60 years, and half of male and female are selected, 20 volunteers of different ages are selected from the nutrient solution prepared by the five embodiments and one comparative example, the nutrient solution continuously drinks 200ML at 10 am every day, the vision of the volunteers is continuously drunk for 6 months and collected at half a month intervals, the average value of the vision change of the 20 volunteers in the 6 months is obtained, and the test results are as follows:
the vision of the volunteers drinking the eye-protecting nutrient solution of the first embodiment is not changed on average, but the volunteers with the age level of 30-40 years show improvement of eye fatigue;
the volunteers who drunk the eye-protecting nutrient solution of example two had no change in their eyesight on average, but each volunteer showed all improvement in eye fatigue;
the vision of the volunteers drinking the eye-protecting nutrient solution of the third embodiment is improved by 25 degrees on average, and each volunteer shows all improvements of eye fatigue;
the vision of the volunteers drinking the eye-protecting nutrient solution of the fourth example is not changed on average, but the volunteers aged 30-60 years show improvement of eye fatigue;
the vision of the volunteers drinking the eye-protecting nutrient solution of the fifth embodiment is not changed on average, but the volunteers with the age level of 40-60 years show improvement of eye fatigue;
the vision of the volunteers drinking the eye-protecting nutrient solution of the sixth embodiment is improved by 25 degrees on average, and each volunteer shows all improvements of eye fatigue;
the vision of the volunteers drinking the eye-protecting nutrient solution of the comparative example did not change on average, and two volunteers showed improvement in eye fatigue.
As can be seen from the above tests, the eye protection effect of the third embodiment is the best, and the fatigue of eyes is relieved in all of the first to fifth embodiments.
The above description of the embodiments is only intended to facilitate the understanding of the method of the invention and its core ideas. It should be noted that, for those skilled in the art, it is possible to make various improvements and modifications to the present invention without departing from the principle of the present invention, and those improvements and modifications also fall within the scope of the claims of the present invention.

Claims (7)

1. The eye-protecting nutrient solution is characterized by comprising the following components in percentage by weight:
3 to 5 percent of hydrolyzed procyanidine,
4 to 5 percent of hydrolyzed vegetable protein,
1 to 2 percent of dipotassium glycyrrhizinate,
1 to 2 percent of riboflavin,
1 to 2 percent of retinol,
3 to 5 percent of soluble protein,
3 to 5 percent of vitamin,
1 to 2 percent of yeast polypeptide,
the balance of water.
2. The eye-protecting nutrient solution according to claim 1, characterized by further comprising the following components in percentage by weight:
10 to 20 percent of traditional Chinese medicine extract,
15 to 30 percent of fruit extract,
5 to 10 percent of flavoring agent,
2 to 5 percent of vitamin,
the balance of water.
3. The eye-protecting nutrient solution as claimed in claim 2, wherein the Chinese herbal extract comprises the following components in percentage by weight:
3 to 5 percent of tuckahoe,
9 to 18 percent of Xiasangju,
15 to 25 percent of medlar,
15 to 25 percent of cassia seed,
1 to 3 percent of astragalus root,
12 to 20 percent of buddleja officinalis,
2 to 4 percent of fructus viticis,
the balance of water.
4. An eye-care nutritional liquid according to claim 2, wherein the fruit extract comprises the following components in percentage by weight:
5 to 8 percent of cucumber,
15% -20% of bananas,
8 to 15 percent of pear,
18 to 25 percent of persimmon,
20% -25% of oranges,
3 to 7 percent of mulberry,
the balance of water.
5. An eye-care nutritional liquid according to claim 1, wherein said flavoring agent is xylitol or sucrose.
6. An eye-protecting nutritional liquid according to claim 1, wherein said vitamin is one or more of vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin C, and vitamin H.
7. The nutrient solution as claimed in claim 6, wherein when the vitamins are vitamin A and vitamin B1, the mass ratio of vitamin A to vitamin B1 is 32: 45.
CN202011416260.9A 2020-12-07 2020-12-07 Eye-protecting nutrient solution Pending CN114366775A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011416260.9A CN114366775A (en) 2020-12-07 2020-12-07 Eye-protecting nutrient solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011416260.9A CN114366775A (en) 2020-12-07 2020-12-07 Eye-protecting nutrient solution

Publications (1)

Publication Number Publication Date
CN114366775A true CN114366775A (en) 2022-04-19

Family

ID=81138671

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011416260.9A Pending CN114366775A (en) 2020-12-07 2020-12-07 Eye-protecting nutrient solution

Country Status (1)

Country Link
CN (1) CN114366775A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115282218A (en) * 2022-06-28 2022-11-04 深圳市艾普生物科技有限公司 Herbal atomized composition for relieving eye fatigue and preparation method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088455A (en) * 1993-10-21 1994-06-29 徐晓东 Nutrition solution for vision care
US20160151437A1 (en) * 2014-06-02 2016-06-02 Viva Pharmaceutical, Inc. Nutritional supplements for improved vision and methods of treating the same
CN108720024A (en) * 2018-05-02 2018-11-02 威海养经堂医药科技有限公司 A kind of activity multienzyme vitamin cell nutrient solution
CN108992544A (en) * 2018-09-12 2018-12-14 西安力邦制药有限公司 A kind of Chinese medicine composition for preventing and treating eye disease
CN110025672A (en) * 2019-05-17 2019-07-19 李文燕 A kind of juvenile shortsightedness accommodation cream and preparation method thereof
CN111558031A (en) * 2020-05-13 2020-08-21 河南钎艺食品有限公司 Pure plant multifunctional eye special nutrient solution and preparation method thereof
CN111821355A (en) * 2020-08-06 2020-10-27 河北康平健康产业有限责任公司 Eyesight-protecting lycium ruthenicum and lutein chewable tablet and preparation method thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088455A (en) * 1993-10-21 1994-06-29 徐晓东 Nutrition solution for vision care
US20160151437A1 (en) * 2014-06-02 2016-06-02 Viva Pharmaceutical, Inc. Nutritional supplements for improved vision and methods of treating the same
CN108720024A (en) * 2018-05-02 2018-11-02 威海养经堂医药科技有限公司 A kind of activity multienzyme vitamin cell nutrient solution
CN108992544A (en) * 2018-09-12 2018-12-14 西安力邦制药有限公司 A kind of Chinese medicine composition for preventing and treating eye disease
CN110025672A (en) * 2019-05-17 2019-07-19 李文燕 A kind of juvenile shortsightedness accommodation cream and preparation method thereof
CN111558031A (en) * 2020-05-13 2020-08-21 河南钎艺食品有限公司 Pure plant multifunctional eye special nutrient solution and preparation method thereof
CN111821355A (en) * 2020-08-06 2020-10-27 河北康平健康产业有限责任公司 Eyesight-protecting lycium ruthenicum and lutein chewable tablet and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"电脑族护眼8大食物", 《中国眼镜科技杂志》 *
侯岩: "中药治疗干眼症的临床研究", 《中国社区医师(医学专业)》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115282218A (en) * 2022-06-28 2022-11-04 深圳市艾普生物科技有限公司 Herbal atomized composition for relieving eye fatigue and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101926483A (en) Medlar and chrysanthemum eyesight-improving intelligence-developing health care drink
CN101700365A (en) Functional beverage for improving vision
CN101269153A (en) Sobering-up composition and preparation method thereof
CN108606190A (en) A kind of blueberry draft composite plant beverage, preparation method and application
CN105362501A (en) Radiation-preventing and eyesight-protecting beverage, and preparation method thereof
CN102443528B (en) Wolfberry yam wine and preparation method thereof
CN104187914A (en) Red pomegranate juice beverage and preparation method thereof
CN101869162A (en) Glossy ganoderma tea and preparation method thereof
CN105031238A (en) Maca traditional Chinese medicine health wine and brewing method thereof
CN105878812B (en) Hangover alleviating beverage prepared from Camellia chrysantha and herba Dendrobii, and its preparation method
CN104207241B (en) A kind of integration of drinking and medicinal herbs composite health care beverage and preparation method thereof
CN105441281A (en) Health wine capable of reinforcing kidney to strengthen yang and preparation method of health wine
CN103349121B (en) Hyperglycemia-hyperlipidemia-hypertension relieving health protection tea and preparation method thereof
CN106387591A (en) Chlorella and green plant juice powder solid beverage
CN114366775A (en) Eye-protecting nutrient solution
CN103141638B (en) Eight-treasure tea for male
CN106509526B (en) Coarse cereal fruit juice and preparation method thereof
CN101228958A (en) Method of extracting amylose and red-yellow pigment from medlar as accretion used for rhodiola rosea beverage
CN105410243A (en) Healthcare tea for health preservation in four seasons
CN114432384A (en) Deuterium-depleted borneol atomized eye protection liquid
CN103829240B (en) A kind of containing Pericarpium Longan, the health product improving acuity of vision and preparation method thereof of core lixiviating solution
CN113243516A (en) Soy sauce with blood sugar regulating effect
CN102894449A (en) Solid beverage capable of beautifying and preparation method thereof
CN107149014A (en) Antipyretic beverage that a kind of suitable insomnia crowd drinks and preparation method thereof
CN1286964C (en) Wolfberry recupration wine and its preparation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20220419

RJ01 Rejection of invention patent application after publication